The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Open Positions

Current vacancies in Lund Stem Cell Center Research Groups:


3 Assistant Professor (associate senior lecturer) positions as part of Lund University Programme for Global Excellence

The past two decades have witnessed a profound transformation in medicine driven by advances in our understanding of the immune system, particularly in oncology and the treatment of autoimmune and inflammatory disorders. Despite this progress, major challenges remain in improving the efficacy and precision of immunotherapies. Overcoming these challenges will require a deeper mechanistic insight to enable the development of rational, next-generation therapeutic strategies. To remain at the forefront of immunotherapy research, Lund University, its Medical and Technical Faculties, and Skåne University Hospital are undertaking a major strategic investment in this area. We invite applications from emerging research leaders with an exceptional track record to conduct ground-breaking research within the field of experimental cancer immunotherapy.

As an Assistant Professor you will develop your qualifications over a period of 5 years after which you may be promoted to a tenured position as a senior lecturer, with opportunities for further career advancement.

A start-up package to support the initial hiring of staff and running costs will be provided. Use the links below to learn more about each individual position, and how to apply:

 


Postdoctoral Position in Translational Immuno-Oncology

The Targeted Therapies in Leukemia research group, led by Associate Professor Marcus Järås at the Division of Clinical Genetics is currently seeking a highly motivated postdoctoral researcher to strengthen their team. The group conducts translational research in immuno-oncology and the successful candidate will primarily work on in vivo gene therapy projects involving CAR-macrophages as a novel treatment strategy for leukemia. The work will include DNA cloning, functional in vitro assays, and studies using an AML PDX mouse model established within the research group.

The successful candidate should have a PhD degree in a relevant field and experience working with functional in vitro and in vivo assays, as well as lentiviral vectors, cancer research Immunology research, sequencing technologies, cell culture, bioinformatics, DNA cloning, and single-cell assays.

Application Deadline: 07 June 2026

 


Open BEYOND Postdoctoral Fellow Positions

Lund Stem Cell Center is a hosting partner in BEYOND, an International Postdoctoral Training Program on Advanced Therapies, offering an exciting opportunity for talented  postdoctoral researchers interested in advancing their careers in this rapidly evolving field.

Co-funded by the European Commission under the Marie Skłodowska-Curie Actions, BEYOND will award 35 fully funded, three-year postdoctoral fellowships across five leading European research institutions. The program delivers high-level, interdisciplinary, and intersectoral training in the field of Advanced Therapy Medicinal Products (ATMPs), is designed to provide a comprehensive, hands-on experience spanning the entire development pathway – from early-stage research to clinical development and patient access.

Lund Stem Cell Center will recruit six postdoctoral fellows who will join the labs of leading researchers including: Professor Malin Parmar, Professor Zaal Kokaia, Professor Anna Falk, Professor Johan Jakobsson, Associate Professor Daniella Rylander Ottosson, and Associate Professor Henrik Ahlenius.

Application Deadline: 30 June 2026


For bachelor and master students looking to propose a dissertation topic or for internships, please visit our research groups pages and Bachelor and Master portal. You are more than welcome to contact our Principal Investigators directly.